MedPath

Phenoxybenzamine Hydrochloride

Phenoxybenzamine Hydrochloride Capsules, USP 10 mg adrenergic, -receptor-blocking agent

Approved
Approval ID

037202a5-e08b-4f9d-9df8-a6dd25027748

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 27, 2017

Manufacturers
FDA

Par Pharmaceutical, Inc.

DUNS: 092733690

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Phenoxybenzamine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code49884-038
Application NumberANDA204522
Product Classification
M
Marketing Category
C73584
G
Generic Name
Phenoxybenzamine Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateNovember 27, 2017
FDA Product Classification

INGREDIENTS (3)

PHENOXYBENZAMINE HYDROCHLORIDEActive
Quantity: 10 mg in 1 1
Code: X1IEG24OHL
Classification: ACTIB
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
LACTOSEInactive
Code: J2B2A4N98G
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Phenoxybenzamine Hydrochloride - FDA Drug Approval Details